| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/19/2009 | US20090074783 isolated and purified protein produced by a naturally occurring Babesia sp. and an isolated and purified nucleic acid encoding the above protein; use in diagnosing and treating a mammal infected with a Babesia sp. |
| 03/19/2009 | US20090074781 Dengue virus peptide vaccine and methods of preparing and using the same |
| 03/19/2009 | US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples |
| 03/19/2009 | US20090074777 Wnt proteins and detection and treatment of cancer |
| 03/19/2009 | US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence |
| 03/19/2009 | US20090074773 Cancer vaccine |
| 03/19/2009 | US20090074768 Activin-actriia antagonists and uses for treating or preventing breast cancer |
| 03/19/2009 | US20090074767 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof |
| 03/19/2009 | US20090074764 Methods for diagnosing and treating neuroendocrine cancer |
| 03/19/2009 | US20090074756 Use of llt1 and/or cd161 for modulatting the activity of cells of the immune system |
| 03/19/2009 | US20090074750 Regulator of basal cellular calcium concentration and methods of use |
| 03/19/2009 | US20090074743 Inositol Pyrophosphates Determine Exocytotic Capacity |
| 03/19/2009 | US20090074740 Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT) |
| 03/19/2009 | US20090074728 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 03/19/2009 | US20090074724 Materials and methods for inhibiting wip1 |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | US20090074712 Methods for Treatment and Prevention of Infection |
| 03/19/2009 | US20090074677 Neuroactive steroid compositions and methods of use therefor |
| 03/19/2009 | US20090074669 PNMT as a novel marker for progenitor cells |
| 03/19/2009 | US20090074666 Peptide vaccine for influenza virus |
| 03/19/2009 | US20090074665 Diagnosis and treatment of cancer:I |
| 03/19/2009 | US20090074659 Cancerous disease modifying antibodies |
| 03/19/2009 | US20090071268 High speed sample supply device |
| 03/19/2009 | DE202007018725U1 Oligonukleotid-Sonden und diese enthaltende Diagnose-Kits zur Bestimmung von Linezolid-Resistenzen Oligonucleotide probes containing them and diagnostic kits for the determination of linezolid resistance |
| 03/19/2009 | DE102007044380A1 Computer-aided studying of probabilistic network from data record of measured, experimentally determined and/or empirical values, comprises studying structure of non-directed graphs having nodes and non-directed edges from the data record |
| 03/19/2009 | DE102007043006A1 Vorrichtung und Verfahren zur Exponierung eines Insekts mit einem Wirkstoff sowie Verfahren zur Bestimmung der Wirkung eines Wirkstoffs auf ein Insekt Apparatus and method for exposing an insect with an active ingredient and method for determining the effect of a drug on an insect |
| 03/19/2009 | DE102005045642B4 Anorganische Markierungspartikel auf der Basis von natürlichen Mikroorganismen zur Kennzeichnung von Produkten zu deren Originalitätsnachweis und Verfahren zur Herstellung Inorganic marking particles on the basis of natural microorganisms for the identification of products to their originality and detection process for preparing |
| 03/19/2009 | CA2736182A1 Apparatus, compositions and methods for rapid competitive homogeneous assay |
| 03/19/2009 | CA2702701A1 Compositions, methods and systems for the simultaneous determination of parentage, identity, sex, genotype and/or phenotype, and breed determination in animals |
| 03/19/2009 | CA2699813A1 Phase ii detoxification and antioxidant activity |
| 03/19/2009 | CA2699786A1 Antipsychotic treatment based on snp genotype |
| 03/19/2009 | CA2699646A1 Mirna expression in human peripheral blood microvesicles and uses thereof |
| 03/19/2009 | CA2699642A1 Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes |
| 03/19/2009 | CA2699506A1 Methods for the preparation of dna microarrays with linear high density probes |
| 03/19/2009 | CA2699385A1 Prostate cancer biomarkers |
| 03/19/2009 | CA2699370A1 Compositions and methods for the identification of inhibitors of retroviral infection |
| 03/19/2009 | CA2699367A1 Live attenuated mycoplasma strains |
| 03/19/2009 | CA2698990A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | CA2698645A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 03/19/2009 | CA2698540A1 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype |
| 03/19/2009 | CA2698534A1 Prediction of qt prolongation based on snp genotype |
| 03/19/2009 | CA2698400A1 Method and composition for cancer diagnosis and treatment |
| 03/19/2009 | CA2698379A1 Methods of using genetic markers and related epistatic interactions |
| 03/19/2009 | CA2698248A1 F1f0-atpase inhibitors and related methods |
| 03/18/2009 | EP2037276A2 Cellular immunity test using peptides fixed to a solid medium |
| 03/18/2009 | EP2037273A1 Universally applicable construction of an analysis element and kit containing the universal construction |
| 03/18/2009 | EP2037271A1 Methods using O6-alkylguanine-DNA alkyltransferases |
| 03/18/2009 | EP2036991A1 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay |
| 03/18/2009 | EP2036990A1 Diagnostic test for susceptibility to B-Raf kinase inhibitors |
| 03/18/2009 | EP2036989A1 Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution |
| 03/18/2009 | EP2036988A1 A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| 03/18/2009 | EP2036987A1 Molecular markers for tumor cell content in tissue samples |
| 03/18/2009 | EP2036986A1 Continuous assay method for measuring receptor- and ion channel-mediated calcium response and subsequent gene expression |
| 03/18/2009 | EP2036925A1 Novel steroid-activated nuclear receptors and uses therefor |
| 03/18/2009 | EP2036924A2 Gene regulatory peptides |
| 03/18/2009 | EP2036557A1 Antitumor agent for thyroid cancer |
| 03/18/2009 | EP2035831A2 Methods of analyzing binding interactions |
| 03/18/2009 | EP2035585A2 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/18/2009 | EP2035584A2 Nanosensors and related technologies |
| 03/18/2009 | EP2035583A2 Prediction of lung cancer tumor recurrence |
| 03/18/2009 | EP2035582A2 Biomarkers for the progression of alzheimer's disease |
| 03/18/2009 | EP2035581A2 Dna composition against tumor stromal antigen fap and methods of use thereof |
| 03/18/2009 | EP2035580A2 Method for establishing the source of infection in a case of fever of unclear aetiology |
| 03/18/2009 | EP2035579A1 Se(r)rs displacement assay |
| 03/18/2009 | EP2035578A2 Identification of a nucleic acid molecule |
| 03/18/2009 | EP2035577A1 A diagnostic composition for hepatocellular carcinoma, a diagnostic kit comprising it and diagnostic methods of hepatocellular carcinoma |
| 03/18/2009 | EP2035576A1 Method for diagnosing cancer by detecting the methylation of transitional zones |
| 03/18/2009 | EP2035575A2 Methods of treatment |
| 03/18/2009 | EP2035574A1 Use of n-acylaminoacylpeptide hydrolase (apeh) as a therapeutic or diagnostic target |
| 03/18/2009 | EP2035573A1 Methods for identifying modulators of eoxin formation |
| 03/18/2009 | EP2035565A2 Methods of enhancing protein incorporation into virus like particles |
| 03/18/2009 | EP2035550A2 Disease model incorporation into an artificial immune system (ais) |
| 03/18/2009 | EP2035544A2 Bacterial strains, compositions including same and probiotic use thereof |
| 03/18/2009 | EP2035541A2 Ablation based laser machining of biomolecule patterns on substrates |
| 03/18/2009 | EP2035540A2 System for isolating biomolecules from a sample |
| 03/18/2009 | EP2035505A1 Optical fluorescent imaging using cyanine dyes |
| 03/18/2009 | EP2035448A2 Neuroactive fragments of app |
| 03/18/2009 | EP2035440A2 Primer and probe sequences for detecting chlamydia trachomatis |
| 03/18/2009 | EP2035439A1 Assessment of risk for colorectal cancer |
| 03/18/2009 | EP2035143A1 Method for analysing amplified nucleic acids |
| 03/18/2009 | EP2035142A1 Lid for pcr vessel comprising probes permitting pcr amplification and detection of the pcr product by hybridisation without opening the pcr vessel |
| 03/18/2009 | EP2035032A2 Methods for ester detoxication |
| 03/18/2009 | EP2034880A1 Patches, systems, and methods for non-invasive glucose measurement |
| 03/18/2009 | EP1954816A4 A method for assessing airborne microorganisms |
| 03/18/2009 | EP1937831A4 Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosls |
| 03/18/2009 | EP1924360B1 Chemical and biological detection arrays |
| 03/18/2009 | EP1789573B1 Method for detecting streptococcus agalactiae using alpha-glucosidase activity |
| 03/18/2009 | EP1702079B1 Methods of attaching oligonucleotides and peptides to solid supports using 2,4-hydrazine-(1,3,5)triazine-activated solid phases |
| 03/18/2009 | EP1583840A4 Target-dependent transcription |
| 03/18/2009 | EP1565579B1 Methods for identifying risk of breast cancer |
| 03/18/2009 | EP1532444B1 Method for analyzing body fluids for the presence of cancer cells and corresponding analysis kits |
| 03/18/2009 | EP1525473B1 Method for protein delivery into cells |
| 03/18/2009 | EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase |
| 03/18/2009 | EP1448797B1 Method and kit for detection of novel pathogen inhibitors |
| 03/18/2009 | EP1436609B1 Microfluidic extraction method |
| 03/18/2009 | EP1432813B1 Detection of bovine viral diarrhea virus in hair samples |
| 03/18/2009 | EP1425385B1 Systems and methods for screening pharmaceutical chemicals |
| 03/18/2009 | EP1381697B1 Circular probe amplification (cpa) of circularized nucleic acid molecules |
| 03/18/2009 | EP1377684A4 Methods for identifying small molecules that bind specific rna structural motifs |
| 03/18/2009 | EP1343815B1 Antibacterial treatments |